» Articles » PMID: 16574915

Vesicular Trafficking of Tyrosine Kinase Receptors and Associated Proteins in the Regulation of Signaling and Vascular Function

Overview
Journal Circ Res
Date 2006 Apr 1
PMID 16574915
Citations 66
Authors
Affiliations
Soon will be listed here.
Abstract

Receptor tyrosine kinases (RTKs) play a pivotal role in the development and function of the cardiovascular system. Ligand-activated RTKs promote numerous downstream signal transduction pathways that lead to vascular permeability, as well as proliferation, migration, and differentiation of vascular endothelia and smooth muscle cells. Ligand binding also promotes internalization of the activated receptors either to downregulate the signaling via degradation of the ligand/receptor complex or to signal from endosomes. However, the outcomes of receptor internalization via clathrin-dependent or caveolar pathways and trafficking mechanisms are incompletely clarified in vascular systems. Activity modulation through endocytosis and vesicular trafficking significantly impacts downstream targets of RTKs such as endothelial nitric oxide synthase (eNOS) and VE-cadherin. RTKs and their associated targets are also transported to the nucleus, where they may directly impact nuclear signaling. Although the nuclear transport pathways are just beginning to be unraveled, it appears that endocytosis and vesicular trafficking are involved. In this review, we discuss the mechanisms by which activated RTKs and the downstream targets eNOS and VE-cadherin may be internalized and transported to various intracellular compartments. How localization and interacting proteins impact protein function and influence signaling is an important theme, as is the potential for modulating signaling through therapeutic targeting of activated receptors and components of the endocytic machinery.

Citing Articles

Deciphering the Role of Copper Homeostasis in Atherosclerosis: From Molecular Mechanisms to Therapeutic Targets.

Lv X, Zhao L, Song Y, Chen W, Tuo Q Int J Mol Sci. 2024; 25(21).

PMID: 39519014 PMC: 11546650. DOI: 10.3390/ijms252111462.


Role of Protein Phosphatases in Tumor Angiogenesis: Assessing PP1, PP2A, PP2B and PTPs Activity.

Fonodi M, Nagy L, Boratko A Int J Mol Sci. 2024; 25(13).

PMID: 38999976 PMC: 11241275. DOI: 10.3390/ijms25136868.


Extracellular Vesicles in Metabolic and Vascular Insulin Resistance.

Malin S, Erdbrugger U J Vasc Res. 2024; 61(3):129-141.

PMID: 38615667 PMC: 11149383. DOI: 10.1159/000538197.


Endomucin selectively regulates vascular endothelial growth factor receptor-2 endocytosis through its interaction with AP2.

Cano I, Wild M, Gupta U, Chaudhary S, Ng Y, Saint-Geniez M Cell Commun Signal. 2024; 22(1):225.

PMID: 38605348 PMC: 11007909. DOI: 10.1186/s12964-024-01606-w.


The P-type ATPase transporter ATP7A promotes angiogenesis by limiting autophagic degradation of VEGFR2.

Ash D, Sudhahar V, Youn S, Okur M, Das A, OBryan J Nat Commun. 2021; 12(1):3091.

PMID: 34035268 PMC: 8149886. DOI: 10.1038/s41467-021-23408-1.